Adage Capital Partners’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,000,000
| Closed | -$3.54M | – | 896 |
|
|
2024
Q3 | $3.54M | Hold |
3,000,000
| – | – | 0.01% | 745 |
|
|
2024
Q2 | $3.66M | Buy |
3,000,000
+1,000,000
| +50% | +$1.22M | 0.01% | 739 |
|
|
2024
Q1 | $4.36M | Buy |
+2,000,000
| New | +$4.36M | 0.01% | 707 |
|
|
2022
Q3 | – | Sell |
-2,000,000
| Closed | -$3.66M | – | 1062 |
|
|
2022
Q2 | $3.66M | Hold |
2,000,000
| – | – | 0.01% | 834 |
|
|
2022
Q1 | $5.34M | Buy |
+2,000,000
| New | +$5.34M | 0.01% | 823 |
|